Multiple Dimensions of Value: Evaluative Frameworks for New Cancer Therapies-Reference-Cited by-同舟云学术

Multiple Dimensions of Value: Evaluative Frameworks for New Cancer Therapies

Published:2016-04-20 Issue:12 Volume:34 Page:1428-1429
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Cheung Matthew C.¹,Sabharwal Mona²,Chambers Alexandra²,Han Dolly²,Sabarre Kelley-Anne²,Chan Kelvin³

Affiliation:

1. Canadian Agency for Drugs and Technology in Health, Sunnybrook Health Sciences Centre, and University of Toronto, Toronto, Ontario, Canada

2. Canadian Agency for Drugs and Technology in Health, Toronto, Ontario, Canada

3. Canadian Agency for Drugs and Technology in Health, Sunnybrook Health Sciences Centre, Canadian Centre for Applied Research in Cancer Control, and University of Toronto, Toronto, Ontario, Canada

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2015.66.4201

Reference7 articles.

1. Five Years of Cancer Drug Approvals

2. New Math on Drug Cost-Effectiveness

3. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

4. Value-Based Cancer Care

5. Informing Canada’s Cancer Drug Funding Decisions with Scientific Evidence and Patient Perspectives: The Pan-Canadian Oncology Drug Review

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Oncology Drug Review Times on Public Funding Recommendations;Current Oncology;2023-08-18

2. Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs;Current Oncology;2021-01-20

3. Value assessment of oncology drugs using a weighted criterion‐based approach;Cancer;2019-12-20

4. Examining Trends in Cost and Clinical Benefit of Novel Anticancer Drugs Over Time;Journal of Oncology Practice;2018-05

5. Evolution of cancer treatment and evolving challenges;Healthcare Management Forum;2017-12-21